Recicort 1.77 mg/ml + 17.7 mg/ml Ear Drops, Solution for Dogs and Cats

País: Reino Unido

Língua: inglês

Origem: VMD (Veterinary Medicines Directorate)

Ingredientes ativos:

Salicylic Acid, Triamcinolone Acetonide

Disponível em:

Le Vet Beheer B.V.

Código ATC:

QD07XB02

DCI (Denominação Comum Internacional):

Salicylic Acid, Triamcinolone Acetonide

Forma farmacêutica:

Ear drops, solution

Tipo de prescrição:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapêutico:

Cats, Dogs

Área terapêutica:

Anti Inflammatory corticosteroid

Status de autorização:

Authorized

Data de autorização:

2017-03-22

Características técnicas

Revised: March 2022
AN: 00478/2021 & 00479/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Recicort 1.77 mg/ml + 17.7 mg/ml ear drops, solution for dogs and cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCES:
Triamcinolone acetonide
1.77 mg
Salicylic acid
17.7 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Ear drops, solution.
Clear colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of otitis externa.
Symptomatic treatment of seborrhoeic dermatitis of the auricle.
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to corticosteroids, salicylic
acid or to any of
the excipients.
Do not use in animals with perforated tympanic membrane. Do not use in
dogs with
demodicosis.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
For an effective treatment of otitis externa it is essential that the
ear canal is
meticulously cleaned and dried before first treatment to remove
cerumen and/or
exudate. Excess hair around the treatment area should be clipped if
necessary.
Revised: March 2022
AN: 00478/2021 & 00479/2021
Page 2 of 6
For an effective treatment of seborrhoeic dermatitis existing scale
and or exfoliative
debris should be removed. Hair surrounding or covering the lesions may
need to be
clipped to enable the veterinary medicinal product to reach the
affected skin.
Seborrhoeic dermatitis may be a primary disorder, but can also occur
as a result of
underlying disorders or disease processes (e.g. allergic disorders,
endocrine
disorders, neoplasia) while otitis externa is only very rarely primary
and occurs
mainly as a result of different underlying causes (predisposing and
perpetuating
factors, neoplasia). Therefore, it is essential to identify any
underlying disease
process and initiate specific treatment, if considered necessary.
Furthermore, infections (bacterial, parasitic or fungal) commonly
occur concurrently
with